RENAISSANCE TECHNOLOGIES LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in ARQT

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$10,389,936

+$2,433,006 QoQ

Shares Held

440,999

+60.9% QoQ

Ownership

0.353%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,447,997,584 across 326 Biotechnology names. ARQT ranks #50 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,389,936	440,999	+60.9%	Shares	Sole	2026-05-14
2025-12-31	$7,956,930	273,999	+1156.9%	Shares	Sole	2026-02-12
2025-03-31	$340,936	21,799	+96.4%	Shares	Sole	2025-05-14
2024-12-31	$154,609	11,099	-94.2%	Shares	Sole	2025-02-13
2024-09-30	$1,786,520	192,099	-51.4%	Shares	Sole	2024-11-13
2023-12-31	$1,276,173	395,100	+507.8%	Shares	Sole	2024-02-13
2022-09-30	$1,242,150	65,000	+501.9%	Shares	Sole	2022-11-14
2022-06-30	$230,148	10,800	-61.0%	Shares	Sole	2022-08-12
2020-06-30	$837,648	27,700	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.